Core Viewpoint - The company Jianfa Zhixin expects a net profit attributable to shareholders of 242 million to 296 million yuan for 2025, representing a year-on-year growth of 6% to 29.65% due to the rapid development of its medical consumables centralized operation (SPD) business, which has a high gross profit margin [1] Group 1 - The company's SPD business is experiencing rapid growth, contributing significantly to overall profitability [1] - The gross profit margin of the SPD business is high, enhancing the company's overall profitability [1] - The company is optimizing its financial structure, resulting in a year-on-year decrease in interest-bearing liabilities [1] Group 2 - The company has engaged in communication and negotiation with financial institutions to reduce financing costs, positively impacting net profit [1] - Financial expenses have decreased year-on-year, further contributing to the increase in net profit [1]
建发致新：预计2025年度净利润为2.42亿元~2.96亿元，同比增长6%~29.65%